NDC 0031-9303
Robitussin Direct Chest Congestion
Guaifenesin
Robitussin Direct Chest Congestion is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Guaifenesin.
| Product ID | 0031-9303_31fb6502-50db-4216-a202-f5604b1469d4 |
| NDC | 0031-9303 |
| Product Type | Human Otc Drug |
| Proprietary Name | Robitussin Direct Chest Congestion |
| Generic Name | Guaifenesin |
| Dosage Form | Tablet, Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-07-15 |
| Marketing Category | OTC MONOGRAPH FINAL / |
| Application Number | part341 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | GUAIFENESIN |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |